# Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)

> **NCT05095792** · — · TERMINATED · sponsor: **Entheon Biomedical Corp.** · enrollment: 1 (actual)

## Conditions studied

- Treatment-resistant Depression

## Interventions

- **OTHER:** Observational - no intervention

## Key facts

- **NCT ID:** NCT05095792
- **Lead sponsor:** Entheon Biomedical Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-09
- **Primary completion:** 2022-10-21
- **Final completion:** 2022-10-21
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Business decision to stop enrollment after 1 participant completed the study. Will not be reopening.
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095792, "Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05095792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*